Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy
A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy
Status: Enrolling
Updated:  7/23/2015
Clinical Research Facility
mi
from
Burlington, VT
Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy
A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy
Status: Enrolling
Updated: 7/23/2015
Clinical Research Facility
mi
from
Burlington, VT
Click here to add this to my saved trials
Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy
A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy
Status: Enrolling
Updated:  7/23/2015
Research Site
mi
from
St Leonards,
Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy
A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy
Status: Enrolling
Updated: 7/23/2015
Research Site
mi
from
St Leonards,
Click here to add this to my saved trials
University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)
Long-term Role of Pioglitazone in Non-Alcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes Mellitus (T2DM).
Status: Enrolling
Updated:  7/24/2015
Bartter Research Unit, Audie L Murphy VA Hospital
mi
from
San Antonio, TX
University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)
Long-term Role of Pioglitazone in Non-Alcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes Mellitus (T2DM).
Status: Enrolling
Updated: 7/24/2015
Bartter Research Unit, Audie L Murphy VA Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
Dietary Interventions in Prediabetes
The Effects of Dietary Supplementation on Hepatic Insulin Action and Glucose Tolerance in Pre-diabetes
Status: Enrolling
Updated:  7/27/2015
The Mayo Clinic
mi
from
Rochester, MN
Dietary Interventions in Prediabetes
The Effects of Dietary Supplementation on Hepatic Insulin Action and Glucose Tolerance in Pre-diabetes
Status: Enrolling
Updated: 7/27/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Birmingham, AL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Gulf Shores, AL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Gulf Shores, AL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Huntsville, AL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Chandler, AZ
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Chandler, AZ
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Goodyear, AZ
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Goodyear, AZ
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Phoenix, AZ
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Little Rock, AR
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Chula Vista, CA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Chula Vista, CA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Fresno, CA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Intarcia
mi
from
Hayward, CA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Intarcia
mi
from
Hayward, CA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Long Beach, CA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Los Angeles, CA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
National City, CA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
National City, CA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Port Hueneme, CA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Port Hueneme, CA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
San Jose, CA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
San Jose, CA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
San Mateo, CA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
San Mateo, CA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Tustin, CA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Tustin, CA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Tustin, CA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Tustin, CA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Valley Village, CA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Valley Village, CA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Walnut Creek, CA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Watsonville, CA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Watsonville, CA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Colorado Springs, CO
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Colorado Springs, CO
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Boca Raton, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Bradenton, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Bradenton, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Celebration, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Celebration, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Clearwater, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Coral Gables, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Coral Gables, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Coral Gables, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Coral Gables, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Daytona Beach, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Hollywood, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Hollywood, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Jacksonville, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Jacksonville, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Jacksonville, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Miami, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Miami, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Miami, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Miami, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Miami, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Miami, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Miami, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
N. Miami Beach, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
N. Miami Beach, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
New Port Richey, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
New Port Richey, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
North Miami Beach, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
North Miami Beach, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Orlando, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Palm Harbor, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Palm Harbor, FL
Click here to add this to my saved trials